We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

JPMorgan Global Healthcare Inclusive - Class A - Income (GBP)

Sell:39,456.00p Buy:41,637.00p Change: 58.00p (0.15%)
Prices as at 24 April 2024
Sell:39,456.00p
Buy:41,637.00p
Change: 58.00p (0.15%)
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
Prices as at 24 April 2024
Sell:39,456.00p
Buy:41,637.00p
Change: 58.00p (0.15%)
Prices as at 24 April 2024
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Our view on this Fund

This fund does not feature on the Wealth Shortlist of funds our analysts believe have the potential to outperform their peers over the long term. This is not a recommendation to sell; however, if you are thinking of adding to your investments, we believe the Wealth Shortlist is a good place to start. View funds on the Wealth Shortlist »

Our view on the sector

Our view on the sector for this fund is not available.

Performance Analysis

Performance analysis for this fund is not available.

Investment Philosophy

Investment philosophy for this fund is not available.

Process and Portfolio Construction

Process and portfolio construction for this fund are not available.

question mark Manager Track Record Based on HL Quantitative Research

This information is currently unavailable.

Fund Track Record

24/04/19 to 24/04/20 24/04/20 to 24/04/21 24/04/21 to 24/04/22 24/04/22 to 24/04/23 24/04/23 to 24/04/24
Annual return 23.84% 13.62% 8.05% 3.08% 2.64%

Please remember past performance is not a guide to future returns. Where no data is shown, figures are not available. This information is provided to help you choose your own investments, remember they can fall as well as rise in value so you may not get back the original amount invested.

Information about the fund

Fund manager biography

Manager Name: Laurence McGrath
Manager start date: 31 October 2019
Manager located in: New York

Laurence McGrath, executive director, is an analyst in Equity Research. An employee since 2010, Laurence is responsible for analyzing and investing in the U.S. Large Cap healthcare equipment and services sector. Before joining the firm, he was a healthcare equipment and services analyst with Pioneer Investments. He holds a Bachelor of Commerce in banking and finance from the University College Dublin and a M.Sc. in investment and treasury management from Dublin City University

Manager Name: Anne Marden
Manager start date: 2 October 2009
Manager located in: .

?Anne Marden, Managing Director, is part of the J.P. Morgan Asset Management International Equity Group - Research Driven Process Team, as Co-Portfolio Manager of the Global Healthcare Strategy, based in London. Anne has been a portfolio manager of the Fund since its launch in 2009. An employee since 1986, Anne has previously had specific research responsibility for the European pharmaceutical and healthcare sectors. Anne obtained a B.A. in Economics from Princeton and earned an M.B.A. from INSEAD. She is a CFA charterholder.

manager photo
Manager Name: Matthew Cohen
Manager start date: 5 January 2015
Manager located in: New York

Matthew G. Cohen, managing director,is a research analyst and portfolio manager in the U.S. Equity Group.  An employee since 2005, Matthew is responsible for research analysis and stock selection of healthcare stocks for the JPMorgan Small Cap Growth and Mid CapGrowth funds.Additionally, he serves as a co-portfolio manager on the JPMorgan Small Cap Growth Fund and a portfoliomanageron the Global Healthcare Fund. Before joining the firm, Matthew was a senior healthcare analyst at Medici Healthcare and a senior analyst covering medical products at Narragansett Asset Management, a New York-based healthcare hedge fund.  Prior to that, Dr. Cohen was a resident surgeon in the Department of General Surgery at the North Shore University Hospital - NYU School of Medicine.  Matthew holds an M.B.A. from New York University's Stern School of Business and an M.D. from McGill University in Montreal.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Benchmark data provided subject to this disclaimer.
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account